Conditions: Cervical Dystonia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 116
Healthy volunteers: no

Brief summary:
The aim of this study is to demonstrate the effectiveness and safety of 500 units of Dysport manufactured at a new manufacturing facility in Europe.

Detailed description:

Arms:
arm 1: Drug: abobotulinumtoxinA (Dysport®) arm 2: Placebo

Interventions: intervention 1: Botulinum toxin type A intervention 2: Placebo
Intervention descriptions: intervention 1: 500 units intervention 2: 500 units

Protocol document: